Drug makers withdraw heartburn medicine in SA

06 Nov 2019

Meanwhile medicine regulators around the world are investigating ranitidine-containing products, triggering both voluntary and mandatory product recalls.

Last week SA’s biggest drug manufacturer, JSE-listed Aspen Pharmacare, announced that it had been forced to restate its financial results for the year to June and write down the value of its heartburn medicine Zantac by R719-m after a nationwide ranitidine recall ordered by the Australian Therapeutic Goods Administration in October.